Literature DB >> 7687968

Mapping of linear B cell epitopes on open reading frames 2- and 3-encoded proteins of hepatitis E virus using synthetic peptides.

P Coursaget1, Y Buisson, N Depril, P le Cann, M Chabaud, C Molinié, R Roue.   

Abstract

Hepatitis E virus (HEV) is the causative agent of non-A, non-B hepatitis which is transmitted by the fecal-oral route and occurs principally in the form of large epidemics and outbreaks in developing countries. Two overlapping synthetic peptides corresponding to overlapping DNA sequences of the ORF 3 of HEV genome were found to be immunoreactive with sera from patients involved in two epidemics of enterically transmitted non-A, non-B hepatitis. The results suggested the existence of two distinct epitopes. The four synthetic peptides representing these two epitopes from Burma and Mexico strains of hepatitis E virus, were used to investigate anti-HEV reactivities. HEV antibodies were detected in 84-88% of HEV-infected individuals according to the peptide used. The results suggest that a peptide-based ELISA can provide an accurate tool for the diagnosis of acute hepatitis type E.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687968     DOI: 10.1111/j.1574-6968.1993.tb06176.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  9 in total

1.  Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies.

Authors:  M A Riddell; F Li; D A Anderson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells.

Authors:  Y Zhang; P McAtee; P O Yarbough; A W Tam; T Fuerst
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

3.  Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus.

Authors:  Y E Khudyakov; E N Lopareva; D L Jue; T K Crews; S P Thyagarajan; H A Fields
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

4.  T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus.

Authors:  R Aggarwal; R Shukla; S Jameel; S Agrawal; P Puri; V K Gupta; A P Patil; S Naik
Journal:  J Viral Hepat       Date:  2007-04       Impact factor: 3.728

5.  Baculovirus expression of chimeric hepatitis B virus core particles with hepatitis E virus epitopes and their use in a hepatitis E immunoassay.

Authors:  A Touze; N Enogat; Y Buisson; P Coursaget
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

6.  Artificial mosaic protein containing antigenic epitopes of hepatitis E virus.

Authors:  Y E Khudyakov; M O Favorov; N S Khudyakova; M E Cong; B P Holloway; N Padhye; S B Lambert; D L Jue; H A Fields
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.

Authors:  Anthony Brown; John S Halliday; Leo Swadling; Richie G Madden; Richard Bendall; Jeremy G Hunter; James Maggs; Peter Simmonds; Donald B Smith; Louisa Vine; Cara McLaughlin; Jane Collier; David Bonsall; Katie Jeffery; Susanna Dunachie; Paul Klenerman; Jacques Izopet; Nassim Kamar; Harry R Dalton; Eleanor Barnes
Journal:  Hepatology       Date:  2016-10-28       Impact factor: 17.425

Review 8.  Viral hepatitis in pregnancy.

Authors:  Mohamed Tarek M Shata; Helal F Hetta; Yeshika Sharma; Kenneth E Sherman
Journal:  J Viral Hepat       Date:  2022-07-07       Impact factor: 3.517

9.  Screening of specific diagnostic peptides of swine hepatitis E virus.

Authors:  Kai Zhao; Qiwen Liu; Ruisong Yu; Zhen Li; Jianyue Li; Hong Zhu; Xiao Wu; Furong Tan; Jinbin Wang; Xueming Tang
Journal:  Virol J       Date:  2009-11-04       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.